UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020919
Receipt number R000021325
Scientific Title Effects of acute phase intensive exercise training in patients with acute decompensated heart failure: The ACTIVE-ADHF Randomized Controlled Trial
Date of disclosure of the study information 2016/02/08
Last modified on 2016/06/19 22:06:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of acute phase intensive exercise training in patients with acute decompensated heart failure: The ACTIVE-ADHF Randomized Controlled Trial

Acronym

ACTIVE-ADHF Trial

Scientific Title

Effects of acute phase intensive exercise training in patients with acute decompensated heart failure: The ACTIVE-ADHF Randomized Controlled Trial

Scientific Title:Acronym

ACTIVE-ADHF Trial

Region

Japan


Condition

Condition

Acute decompensated heart failure

Classification by specialty

Cardiology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of acute phase intensive exercise training in patients with acute decompensated heart failure

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Six-minute walk distance [Time Frame: Measured at baseline and 2 weeks]

Key secondary outcomes

Lower extremity function, Physical activity, Cardiac and renal function, Quality of life [Time Frame: Measured at baseline and 2 weeks]

Mortality and rehospitalization rates (measured at 30 days and 3 months) [Time Frame: Measured as events occur during the lifespan of the trial]


Subgroup analysis (Statistical significance level of p-value for interaction: <0.1): Age >=65 years, Gender, LVEF >=50%, Six-minute walk distance >median value


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

1) Usual care
2) Supervised exercise therapy for 30-60 minutes per day, 5-7 days per week
3) Instruction of physical activity

Interventions/Control_2

1) Usual care

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients who were hospitalized for acute exacerbation of heart failure
2) Aged 30 years or older

Key exclusion criteria

1) BNP < 100 pg/ml at admission
2) Cognitive dysfunction
3) Acute coronary syndrome
4) Significant myocardial ischemia during low-intensity exercise
5) Resting heart rate > 120/min
6) Acute infective endocarditis, myocarditis, and pericaritis
7) Presence of a recent hospitalization for heart failure (< 1 month)
8) Severe symptomatic aortic stenosis, mitral stenosis, and hypertrophic obstructive cardiomyopathy
9) Severe pulmonary hypertension
10) Intracardiac thrombus
11) Untreated life-threatening arrhythmia
12) Resting blood pressure > 180 mmHg
13) Ongoing orthopnea
14) Requiring high inotropic support
15) Patients with circulatory assist device
16) Patients with inadequate oxygenation
17) Patients with mechanical ventilation
18) History of aortic dissection, or presence of aortic aneurysm or aortic dissection
19) Patients with uncontrolled diabetes
20) Peripheral arterial disease (Fontain 3-4)
21) Recent embolism
22) Patients undergoing hemodialysis
23) Serum creatinine > 3.0 mg/dl
24) Severe anemia
25) Short life expectancy due to advanced disease other than heart failure
26) Patients who needed assistance for walking a month before hospitalization
27) Pregnant, lactational woman, patients may be pregnant

Target sample size

135


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kentaro Kamiya

Organization

Kitasato University Hospital

Division name

Rehabilitation

Zip code


Address

1-15-1 Kitasato, Minami-ku, Sagamihara city, Kanagawa

TEL

042-778-8413

Email

kamiken.pt@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Kentaro Kamiya

Organization

Kitasato University Hospital

Division name

Rehabilitation

Zip code


Address

1-15-1 Kitasato, Minami-ku, Sagamihara city, Kanagawa

TEL

042-778-8413

Homepage URL


Email

kamiken.pt@gmail.com


Sponsor or person

Institute

Kitasato University Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Kitasato University Medical Center, Kameda Medical Center

Name of secondary funder(s)

Japanese Physical Therapy Association


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北里大学病院(神奈川県),北里大学メディカルセンター(埼玉県), 亀田総合病院(千葉県)


Other administrative information

Date of disclosure of the study information

2016 Year 02 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2015 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2016 Year 06 Month 03 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 02 Month 07 Day

Last modified on

2016 Year 06 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021325


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name